Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation

por Starlinger, P, Alidzanovic, L, Schauer, D, Maier, T, Nemeth, C, Perisanidis, B, Tamandl, D, Gruenberger, B, Gruenberger, T, Brostjan, C
Publicado 2012